International Cannabis Weekly: 39
April 4, 2018
Highlights
Share this story
Business & Investment
- Israel exports intellectual property and expertise rather than cannabis.
- The Greek government is actively supporting a domestic cannabis industry.
- Canadian firms will have to wait as Germany stalls on licencing process.
- Is it worth investing in Israel’s medical cannabis industry?
- CBD products are becoming increasingly popular among millennials.
- Blue Moon is launching a THC-infused craft beer.
- Cannabis could become a vital source of renewable energy.
Note – Prohibition Partners will be attending ICBC Berlin next week.
Highlights
Share this story
Regulation & Politics
- Most Luxembourg residents want cannabis legalised for personal use.
- Harvard study shows liberal cannabis policies fuel economic innovation.
- Harsh cannabis policies in Belarus are being criticised by human rights activists.
- UK Home Office asked to consider cannabis treatment for five year old boy.
- A medical cannabis bill is advancing in South Korea.
Highlights
Share this story
Health & Science
- Cannabis can prevent dangerous drug use among at risk youths.
- Two new studies show how cannabis can help tackle the opioid epidemic.
- Cannabis for veterinary patients gets research funding.
- Preclinical study on antitumour effects of cannabis compounds shows positive results.
Highlights
Share this story
The European Cannabis Report
Highlights
Share this story
Cannabis Europa
Cannabis Europa, a conference dedicated to shaping the future of medical cannabis in Europe, will take place on 22nd May at the Barbican in London.
Last 2 weeks of early bird tickets – buy now
Highlights
Share this story
Market Focus
WHAT DOES THE FUTURE HOLD FOR THE CZECH CANNABIS INDUSTRY?
The Czech Republic has had a complex relationship with cannabis. With the attitudes towards legal cannabis changing throughout Europe, could the country gain a foothold in the emerging marketplace?
Insights
on the global cannabis industry
International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.